Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Jarvis

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Frontiers in Bioscience : a Journal and Virtual Library|June 5, 2002
Mechanisms of human cytomegalovirus persistence and latencyMichael A Jarvis, Jay A Nelson
Current Opinion in Microbiology|August 6, 2002
Human cytomegalovirus persistence and latency in endothelial cells and macrophagesMichael A Jarvis, Jay A Nelson
Expert Opinion on Investigational Drugs|February 17, 2021
Targeting Ebola virus replication through pharmaceutical interventionFrederick Hansen, Heinz Feldmann, Michael A Jarvis
Expert Review of Vaccines|November 3, 2015
Self-disseminating vaccines for emerging infectious diseasesAisling A Murphy, Alec J Redwood, Michael A Jarvis
Microorganisms|April 30, 2021
Lassa Virus Treatment OptionsFrederick Hansen, Michael A Jarvis, Heinz Feldmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 6, 2013
The context of gene expression defines the immunodominance hierarchy of cytomegalovirus antigensIryna Dekhtiarenko, Michael A Jarvis, Zsolt Ruzsics, et al.
Journal of Virology|March 16, 2005
Antigenic domain 1 is required for oligomerization of human cytomegalovirus glycoprotein BWilliam J Britt, Michael A Jarvis, Derek D Drummond, et al.
The Journal of Infectious Diseases|July 8, 2024
Combined Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 Reduces Molnupiravir-Induced Mutagenicity and Prevents Selection for Nirmatrelvir/Ritonavir Resistance MutationsShuntai Zhou, Nathan Long, Kyle Rosenke, et al.
Journal of Virology|December 28, 2005
Human cytomegalovirus entry into epithelial and endothelial cells depends on genes UL128 to UL150 and occurs by endocytosis and low-pH fusionBrent J Ryckman, Michael A Jarvis, Derek D Drummond, et al.
Journal of Virology|December 25, 2009
A human cytomegalovirus gO-null mutant fails to incorporate gH/gL into the virion envelope and is unable to enter fibroblasts and epithelial and endothelial cellsPaul T Wille, Amber J Knoche, Jay A Nelson, et al.
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Frontiers in Bioscience : a Journal and Virtual Library|June 5, 2002
Mechanisms of human cytomegalovirus persistence and latencyMichael A Jarvis, Jay A Nelson
Current Opinion in Microbiology|August 6, 2002
Human cytomegalovirus persistence and latency in endothelial cells and macrophagesMichael A Jarvis, Jay A Nelson
Expert Opinion on Investigational Drugs|February 17, 2021
Targeting Ebola virus replication through pharmaceutical interventionFrederick Hansen, Heinz Feldmann, Michael A Jarvis
Expert Review of Vaccines|November 3, 2015
Self-disseminating vaccines for emerging infectious diseasesAisling A Murphy, Alec J Redwood, Michael A Jarvis
Microorganisms|April 30, 2021
Lassa Virus Treatment OptionsFrederick Hansen, Michael A Jarvis, Heinz Feldmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 6, 2013
The context of gene expression defines the immunodominance hierarchy of cytomegalovirus antigensIryna Dekhtiarenko, Michael A Jarvis, Zsolt Ruzsics, et al.
Journal of Virology|March 16, 2005
Antigenic domain 1 is required for oligomerization of human cytomegalovirus glycoprotein BWilliam J Britt, Michael A Jarvis, Derek D Drummond, et al.
The Journal of Infectious Diseases|July 8, 2024
Combined Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 Reduces Molnupiravir-Induced Mutagenicity and Prevents Selection for Nirmatrelvir/Ritonavir Resistance MutationsShuntai Zhou, Nathan Long, Kyle Rosenke, et al.
Journal of Virology|December 28, 2005
Human cytomegalovirus entry into epithelial and endothelial cells depends on genes UL128 to UL150 and occurs by endocytosis and low-pH fusionBrent J Ryckman, Michael A Jarvis, Derek D Drummond, et al.
Journal of Virology|December 25, 2009
A human cytomegalovirus gO-null mutant fails to incorporate gH/gL into the virion envelope and is unable to enter fibroblasts and epithelial and endothelial cellsPaul T Wille, Amber J Knoche, Jay A Nelson, et al.
Pageof 7